Skip to main content
. 2022 Feb 1;50(1):31–36. doi: 10.5152/TJAR.2021.1422

Table 2.

Overall Pain Incidence and Comparison of Groups According to Verbal Pain Scores During Propofol Injection

Saline n (%) Tenoxicam, 10 mg n (%) Tenoxicam, 20 mg n (%)
Verbal Pain Scale Group 1 (n = 40) Group 2 (n = 40) Group 3 (n = 40) P
0 (no pain) 6 (15%) 10 (25) 16 (40)a .013*
1 (mild) 8 (20%) 10 (25%) 14 (35%)
2 (moderate) 14 (35%) 14 (35%) 8 (20%)
3 (severe) 12 (30%) 6 (15%) 2 (5%)b
Overall incidence 34 (85%) 30 (75%)# 24 (60%)** .039*

Data are presented as number of patients (%), * P < .05 was considered significant, # P = .264 compared with group 1, ** P = .012 compared with group 1.

aAccording to group 1, P = .033.

bAccording to group 1, P = .008.